Private equity firm Segulah has announced it is looking to sell its complete stake in Medstop Group Holding AB, whose pharmacy chain holds a 7.5 percent share of the Swedish pharmacy market, to Oriola-KD Holdings Sverige AB. The deal will result in Oriola’s possession of about 300 pharmacies around the nation, increasing its stake in the market from 14 percent to about 21 percent. Segulah originally acquired its 100 percent stake in the Medstop pharmacy chain as part of the privatization of Apoteket AB, a former pharmacy monopoly, in February 2010.
Featured News
Apartment Giants AvalonBay, Equity Weigh $50 Billion Merger
Apr 30, 2026 by
CPI
Apple Challenges Indian Competition Regulator Over Financial Data Demand in Antitrust Case
Apr 30, 2026 by
CPI
EU Judges Leave Final Decision on Portuguese Football Hiring Pact to National Court
Apr 30, 2026 by
CPI
State AGs Form Bipartisan Task Force To Support Guardrails Around AI
Apr 30, 2026 by
CPI
Brazil Opens Antitrust Case Into Alleged Airline Price Coordination
Apr 30, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Unilateral Effects
Apr 28, 2026 by
CPI
A Net Present Value Approach to Merger Analysis
Apr 28, 2026 by
Joseph J Simons & Malcolm Coate
Generative AI and Competitive Disruption: Increasingly Relevant for Merger Analysis?
Apr 28, 2026 by
Andrea Coscelli, Emily Chissell, Nitika Bagaria & Tega Akati-Udi
Non-Price Unilateral Effects In Media Mergers
Apr 28, 2026 by
Lapo Filistrucchi & Teresa Oriani
Ecosystem Mergers and Unilateral Effects? A Framework for Assessing the Ecosystem Theory of Harm
Apr 28, 2026 by
Ethel Fonseca, George Tucker & Helder Vasconcelos